** Medical equipment maker NanoString Technologies' shares
NSTG.O fall nearly 31% to $22.85 in after-market trade
** Co reports preliminary product and service revenue of $31
million for Q1, but says it "fell short of our expectation"
urn:newsml:reuters.com:*:nBw8sBj6La
** CEO Brad Gray says Q1 revenue may have been hit by
"uneven sales execution" and "impact of changes made to re-align
our expanded commercial team early in the year"
** Five of six brokerages rate the stock "buy" or higher,
one "hold"; their median PT is $51
** Up to Tuesday's close, stock had fallen 22% YTD
(Reporting by Leroy Leo in Bengaluru)
((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))